BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Angiopoietin-like 3 (ANGPTL3)

September 24, 2015 7:00 AM UTC

Mouse studies suggest inhibiting ANGPTL3 could help treat metabolic disorders. Loss-of-function ANGPTL3 mutations in healthy subjects have been associated with low levels of plasma triglycerides and h...